About Alantos Pharmaceuticals
Alantos Pharmaceuticals is a company based in Cambridge (United States) founded in 1999 was acquired by Amgen in June 2007.. Alantos Pharmaceuticals has raised $47.7 million across 2 funding rounds from investors including Amgen, ABN AMRO and Oxford Bioscience Partners. Alantos Pharmaceuticals operates in a competitive market with competitors including Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics, Cellino and Adocia, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Alantos Pharmaceuticals
Alantos Pharmaceuticals has successfully raised a total of $47.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $20.0M
-
First Round
First Round
(18 Jul 2003)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2005 | Amount | Series B - Alantos Pharmaceuticals | Valuation |
investors |
|
| Jul, 2003 | Amount | Series B - Alantos Pharmaceuticals | Valuation | Oxford Bioscience Partners , Earlybird |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alantos Pharmaceuticals
Alantos Pharmaceuticals has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, ABN AMRO and Oxford Bioscience Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage VC firm investing in the US and Korea
|
Founded Year | Domain | Location | |
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alantos Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alantos Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alantos Pharmaceuticals Comparisons
Competitors of Alantos Pharmaceuticals
Alantos Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics, Cellino and Adocia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alantos Pharmaceuticals
Frequently Asked Questions about Alantos Pharmaceuticals
When was Alantos Pharmaceuticals founded?
Alantos Pharmaceuticals was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Where is Alantos Pharmaceuticals located?
Alantos Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Alantos Pharmaceuticals a funded company?
Alantos Pharmaceuticals is a funded company, having raised a total of $47.7M across 2 funding rounds to date. The company's 1st funding round was a Series B of $27.7M, raised on Jul 18, 2003.
What does Alantos Pharmaceuticals do?
Founded in 1999 in Cambridge, United States, Alantos Pharmaceuticals operated in the biotechnology sector, focusing on small molecule therapeutics for type 2 diabetes. Development efforts centered on a lead DPP-IV inhibitor candidate, which remained in early clinical testing as of 2007. The company, previously known as Therascope, was acquired by Amgen in July 2007 for 300 million, concluding its independent operations.
Who are the top competitors of Alantos Pharmaceuticals?
Alantos Pharmaceuticals's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
Who are Alantos Pharmaceuticals's investors?
Alantos Pharmaceuticals has 8 investors. Key investors include Amgen, ABN AMRO, Oxford Bioscience Partners, Earlybird, and Heidelberg Innovationsfonds Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.